Venetoclax as a single agent and in combination with PI3K ‐MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma
Source: British Journal of Haematology - Category: Hematology Authors: Huijuan Jiang, Tint Lwin, Xiaohong Zhao, Yuan Ren, Grace Li, Lynn Moscinski, Bijal Shah, Jianguo Tao Tags: Correspondence Source Type: research